Squarepoint’s Equillium EQ Stock Holding History

Squarepoint’s Portfolio EQ Stock Details EQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,025	Closed	-$20.1K	–	4572
2026 Q1	$20.1K	Buy	+10,025	New	+$16.5K	﹤0.01%	4175
2021 Q1	–	Sell	-20,235	Closed	-$108K	–	3246
2020 Q4	$108K	Buy	+20,235	New	+$106K	﹤0.01%	2707

Other funds holding EQ

Jupiter Topco New York $245B AUM

Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Squarepoint's EQ Position: Q2 2026 in Review

Squarepoint sold out of Equillium (EQ) in Q2 2026, closing a stake of 10,025 shares — an estimated $20.1K sold.

Squarepoint first reported a position in EQ in Q4 2020 and held it in 2 quarters. The position peaked at $108K in Q4 2020. 60 funds tracked by Wall St. Rank hold EQ as of Q2 2026.

Squarepoint reported no remaining Equillium position as of Q2 2026 after selling out during the quarter.
Squarepoint sold 10,025 Equillium shares in Q2 2026, an estimated $20.1K.
Squarepoint first reported a position in Equillium in Q4 2020 and held it in 2 quarters.
Squarepoint's Equillium position peaked at $108K in Q4 2020.
60 funds tracked by Wall St. Rank held Equillium as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.